Name | SMOLENSK-FARMATSIYA, OAO |
|---|
INN | 6731044438 |
|---|
KPP | 673101001 |
|---|
OGRN | 1036758329541 |
|---|
OKPO | 1904991 |
|---|
FFSM | 08887-A |
|---|
Address | 214019, Smolenskaya Oblast', g. Smolensk, p Tikhvinka, d. D.10 |
|---|
Phone | +7 (905) 163-05-50 Contact details |
|---|
Fax | +7 (481) 255-40-71 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 21.20 | Additional activity | Manufacturers of drugs and pharmaceuticals and medical products | | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | | All types of activities | | 47.19 | Additional activity | Other retail stores with | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.78.2 | Additional activity | Photo specialty retailers | | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings | | 86.90 | Additional activity | Activities in the field of medicine other |
Registration date | 03.11.2003 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram po Promyshlennomu rayonu g.Smolenska |
|---|
|
SMOLENSK-FARMATSIYA, OAO (Smolensk Oblast; INN 6731044438) was registered on 3 Nov 2003. The company's authorized capital as of July 1, 2012 was 1052000 rub. Type of ownership of SMOLENSK-FARMATSIYA, OAO - Open joint-stock companies. Form of ownership of SMOLENSK-FARMATSIYA, OAO - Combined Russian property with a share of the property of constituent entities of the Russian Federation. Principal activities of SMOLENSK-FARMATSIYA, OAO: retailing drugs in specialized stores (pharmacies) (47.73), manufacturers of drugs and pharmaceuticals and medical products (21.20), wholesale of furniture, carpets and lighting equipment (46.46.1). |
Economic indicators2023
Net profit (RAS) of SMOLENSK-FARMATSIYA, OAO grew over 2023 2.18 times to 13.88 million RUB from 6.38 million RUB over 2022, the company informed. Revenue increased in the accounting period by 9.54% to 410.73 million RUB from 374.94 million RUB over 2022; cost of goods sold grew by 7.81% to 277.73 million RUB from 257.61 million RUB; sales profit went up by 42.87% to 24.56 million RUB from 17.19 million RUB. 2022
Net profit (RAS) of SMOLENSK-FARMATSIYA, OAO dropped in 2022 by 43.15% to 6.38 million RUB from 11.22 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 1.24% to 374.94 million RUB from 379.65 million RUB in 2021; cost of goods sold decreased by 3.49% to 257.61 million RUB from 266.92 million RUB; sales profit fell by 12.70% to 17.19 million RUB from 19.69 million RUB. 2021
Net profit (RAS) of SMOLENSK-FARMATSIYA, OAO grew over 2021 9.98 times to 9.42 million RUB from 944.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 8.02% to 379.65 million RUB from 351.48 million RUB over 2020; cost of goods sold grew by 7.61% to 266.92 million RUB from 248.03 million RUB; sales profit went up 2.06 times to 19.69 million RUB from 9.54 million RUB. 2020
Net profit (RAS) of SMOLENSK-FARMATSIYA, OAO made up 944.00 thousand RUB over 2020 compared to net loss of 1.28 million RUB over 2019, the company informed. Revenue increased in the accounting period by 12.29% to 351.48 million RUB from 313.01 million RUB over 2019; cost of goods sold grew by 17.59% to 248.03 million RUB from 210.92 million RUB; sales profit went up 2.77 times to 9.54 million RUB from 3.44 million RUB. 2019
Net loss (RAS) of SMOLENSK-FARMATSIYA, OAO dropped over 2019 7.66 times to 1.28 million RUB from 9.79 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 2.49% to 313.01 million RUB from 305.41 million RUB over 2018; cost of goods sold grew by 2.72% to 210.92 million RUB from 205.35 million RUB; sales profit made up 3.44 million RUB compared to sales loss of 4.53 million RUB. 2018
Net loss (RAS) of SMOLENSK-FARMATSIYA, OAO increased by 20.51% to 9.79 million RUB from 8.13 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 6.48% to 305.41 million RUB from 326.56 million RUB in 2017; cost of goods sold decreased by 9.82% to 205.35 million RUB from 227.72 million RUB; sales loss grew by 7.63% to 4.53 million RUB from 4.21 million RUB. 2017
Net loss (RAS) of SMOLENSK-FARMATSIYA, OAO increased by 17.32% to 8.13 million RUB from 6.93 million RUB over 2016, the company informed. Revenue decreased in the accounting period by 13.57% to 326.56 million RUB from 377.84 million RUB in 2016; cost of goods sold decreased by 16.32% to 227.72 million RUB from 272.13 million RUB; sales loss made up 4.21 million RUB compared to sales profit of 1.51 million RUB. 2016
Net loss (RA) of SMOLENSK-FARMATSIYA, OAO made up 6.93 million RUB over 2016 compared to net profit of 118.00 thousand RUB over 2015, the company informed. Revenue decreased in the accounting period by 10.33% to 377.84 million RUB from 421.36 million RUB in 2015; cost of goods sold decreased by 13.27% to 272.13 million RUB from 313.78 million RUB; sales profit made up 1.51 million RUB compared to sales loss of 14.75 million RUB. 2014
Net loss (RAS) of SMOLENSK-FARMATSIYA, OAO increased by 11.44% to 27.79 million RUB from 24.94 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 15.21% to 535.59 million RUB from 631.67 million RUB in 2013; cost of goods sold decreased by 17.07% to 401.00 million RUB from 483.56 million RUB; sales loss grew by 23.44% to 24.75 million RUB from 20.05 million RUB. 2013
Net loss (RA) of SMOLENSK-FARMATSIYA, OAO made up 24.94 million RUB over 2013 compared to net profit of 2.25 million RUB over 2012, the company informed. Revenue decreased in the accounting period by 34.83% to 631.67 million RUB from 969.21 million RUB in 2012; cost of goods sold decreased by 34.11% to 483.56 million RUB from 733.84 million RUB; sales loss made up 20.05 million RUB compared to sales profit of 49.98 million RUB. 2012
Net profit (RAS) of Smolensk - Farmaciya, OAO dropped in 2012 6.45 times to 2.25 million RUB from 14.52 million RUB over the same period in 2011, the company informed. Cost of goods sold decreased by 4.79% to 733.84 million RUB from 770.73 million RUB; sales profit went up by 7.82% to 49.98 million RUB from 46.35 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|